Special report of the U.S. Senate Special Committee on Aging on the sudden price spikes in off-patent prescription drugs :
Special report of the U.S. Senate Special Committee on Aging on the sudden price spikes in off-patent prescription drugs : the monopoly business model that harms patients, taxpayers, and the U.S. health system.
Sudden price spikes in off-patent prescription drugs : the monopoly business model that harms patients, taxpayers, and the U.S. health system
- 1 online resource (iii, 130 pages) : illustrations.
- Report / 114th Congress, 2d session, Senate ; 114-429 .
- United States. Congress. Senate. Report ; 114-429. .
Paper version available for sale by the Superintendent of Documents, United States Government Publishing Office. "February 11, 2016." CRDP Program record.
Includes bibliographical references.
Prescription pricing--United States.
Drugs--Prices--United States.
Generic drugs--United States.
Antitrust law--United States.
Competition--United States.
Consumer protection--United States.
Pharmaceutical industry--Moral and ethical aspects--United States.
Legislative materials.
KF31.5 / .A3 2016a
1008-G (online)
Y 1.1/5:114-429
Paper version available for sale by the Superintendent of Documents, United States Government Publishing Office. "February 11, 2016." CRDP Program record.
Includes bibliographical references.
Prescription pricing--United States.
Drugs--Prices--United States.
Generic drugs--United States.
Antitrust law--United States.
Competition--United States.
Consumer protection--United States.
Pharmaceutical industry--Moral and ethical aspects--United States.
Legislative materials.
KF31.5 / .A3 2016a
1008-G (online)
Y 1.1/5:114-429